Biomarkers in colorectal liver metastases: Rising complexity and unknown clinical significance?

Abstract Surgical resection of the liver is the standard treatment for colorectal liver metastases, but 70% of patients still experience recurrence, resulting in limited survival. Molecular biomarkers promise guidance within the selection process of individualized treatment and provide better progno...

Full description

Bibliographic Details
Main Authors: Markus K. Diener, Stefan Fichtner‐Feigl
Format: Article
Language:English
Published: Wiley 2021-07-01
Series:Annals of Gastroenterological Surgery
Subjects:
Online Access:https://doi.org/10.1002/ags3.12454